2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Ascierto PA, Grimaldi AM, Anderson AC, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi FS, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. Journal Of Translational Medicine 2014, 12: 277. PMID: 25348889, PMCID: PMC4232645, DOI: 10.1186/s12967-014-0277-z.Peer-Reviewed Original ResearchConceptsProlong progression-free survivalOverall survivalMelanoma patientsMetastatic melanomaPathway inhibitorTumor microenvironmentImmune-modulating antibodiesLigand 1 pathwayMelanoma Bridge meetingProgression-free survivalMetastatic melanoma patientsCell death 1Adoptive cell transferNovel therapeutic targetContemporary clinical managementImportance of biomarkersFuture drug developmentMitogen-activated protein kinase pathway inhibitorsDifferent immunotherapiesImmune inhibitoryMelanoma BridgeDurable responsesSystemic therapyDeath-1Immune therapy
2007
Roadmap for New Opportunities in Melanoma Research
Herlyn M, Halaban R, Ronai Z, Schuchter L, Berwick M, Pinkel D. Roadmap for New Opportunities in Melanoma Research. Seminars In Oncology 2007, 34: 566-576. PMID: 18083380, DOI: 10.1053/j.seminoncol.2007.09.004.Peer-Reviewed Original Research